David Raben, the Chief Medical Officer of $BCAX, sold 5,500 shares of the company on 03-25-2026 for an estimated $104,229. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.0% of their shares of this class of stock. Following this trade, they now own 55,286 shares of this class of $BCAX stock.
$BCAX Insider Trading Activity
$BCAX insiders have traded $BCAX stock on the open market 45 times in the past 6 months. Of those trades, 1 have been purchases and 44 have been sales.
Here’s a breakdown of recent trading of $BCAX stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, L.P. RA purchased 300,000 shares for an estimated $4,800,000
- RYAN COHLHEPP (President and COO) has made 0 purchases and 16 sales selling 121,869 shares for an estimated $2,231,506.
- IVAN HYEP (Chief Financial Officer) has made 0 purchases and 11 sales selling 92,000 shares for an estimated $1,685,177.
- CLAIRE MAZUMDAR (Chief Executive Officer) has made 0 purchases and 9 sales selling 89,131 shares for an estimated $1,680,055.
- DAVID RABEN (Chief Medical Officer) has made 0 purchases and 7 sales selling 55,000 shares for an estimated $1,020,847.
- LARA MEISNER (Chief Legal Officer) sold 33,807 shares for an estimated $498,653
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BCAX Hedge Fund Activity
We have seen 88 institutional investors add shares of $BCAX stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 2,646,285 shares (+inf%) to their portfolio in Q4 2025, for an estimated $44,536,976
- FRANKLIN RESOURCES INC added 1,620,025 shares (+inf%) to their portfolio in Q4 2025, for an estimated $27,265,020
- VESTAL POINT CAPITAL, LP removed 1,525,000 shares (-29.9%) from their portfolio in Q4 2025, for an estimated $25,665,749
- BLACKSTONE INC. removed 1,224,336 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $20,605,574
- STATE STREET CORP added 1,059,260 shares (+179.5%) to their portfolio in Q4 2025, for an estimated $17,827,345
- FORESITE CAPITAL MANAGEMENT VI LLC removed 949,260 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $14,988,815
- CITADEL ADVISORS LLC added 772,258 shares (+inf%) to their portfolio in Q4 2025, for an estimated $12,997,102
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BCAX Price Targets
Multiple analysts have issued price targets for $BCAX recently. We have seen 6 analysts offer price targets for $BCAX in the last 6 months, with a median target of $29.0.
Here are some recent targets:
- Tazeen Ahmad from B of A Securities set a target price of $35.0 on 03/25/2026
- Reni J. Benjamin from Citizens set a target price of $31.0 on 01/29/2026
- David Nierengarten from Wedbush set a target price of $30.0 on 01/13/2026
- Jeet Mukherjee from BTIG set a target price of $28.0 on 01/08/2026
- Joseph Catanzaro from Mizuho set a target price of $18.0 on 12/18/2025
- Eva Fortea Verdejo from Wells Fargo set a target price of $11.0 on 11/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
